NYSE: DLBDolby Laboratories Inc Stock
$79.58+0.42 (+0.53%)
Updated Apr 24, 2024
DLB Price
$79.58
Fair Value Price
N/A
Market Cap
$7.61B
52 Week Low
$75.87
52 Week High
$91.02
P/E
40.4x
P/B
3.24x
P/S
6.42x
PEG
52.91x
Dividend Yield
1.43%
Revenue
$1.28B
Earnings
$188.26M
Gross Margin
88.3%
Operating Margin
15%
Profit Margin
14.7%
Debt to Equity
0.24
Operating Cash Flow
$319M
Beta
0.95
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A
DLB Overview
Dolby Laboratories, Inc. offers audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates most of its revenue from licensing its technology to consumer electronics manufacturers around the world. Dolby Labs was founded in 1965 and is headquartered in San Francisco, CA.
Zen Score
–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DLB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DLB ($79.58) is trading above its intrinsic value of $11.34, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DLB is good value based on its earnings relative to its share price (40.4x), compared to the US market average (41.27x)
P/E vs Market Valuation
DLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more DLB due diligence checks available for Premium users.
Be the first to know about important DLB news, forecast changes, insider trades & much more!
DLB News
Valuation
DLB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
40.4x
Industry
35.35x
Market
41.27x
DLB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DLB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
DLB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.24x
Industry
4.79x
DLB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DLB price to earnings growth (PEG)
For valuing profitable companies with growth potential
DLB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
DLB's financial health
Profit margin
Revenue
$315.6M
Net Income
$67.0M
Profit Margin
21.2%
DLB's Earnings (EBIT) of $192.04M... subscribe to Premium to read more.
Interest Coverage Financials
DLB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.9B
Liabilities
$573.2M
Debt to equity
0.24
DLB's short-term assets ($1.45B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DLB's short-term assets ($1.45B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DLB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
DLB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$8.4M
Investing
$633.0k
Financing
-$125.1M
DLB's operating cash flow ($319.10M)... subscribe to Premium to read more.
Debt Coverage Financials
DLB vs Specialty Business Service Stocks
Dolby Laboratories Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.